SPIRIT 2013 statement: defining standard protocol items for clinical trials.

The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting, and appraisal. However, trial protocols and existing protocol guidelines vary greatly in content and quality. This article describes the systematic development and scope of SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013, a guideline for the minimum content of a clinical trial protocol.The 33-item SPIRIT checklist applies to protocols for all clinical trials and focuses on content rather than format. The checklist recommends a full description of what is planned; it does not prescribe how to design or conduct a trial. By providing guidance for key content, the SPIRIT recommendations aim to facilitate the drafting of high-quality protocols. Adherence to SPIRIT would also enhance the transparency and completeness of trial protocols for the benefit of investigators, trial participants, patients, sponsors, funders, research ethics committees or institutional review boards, peer reviewers, journals, trial registries, policymakers, regulators, and other key stakeholders.

[1]  Rachael B. Zuckerman,et al.  Measuring the Incidence, Causes, and Repercussions of Protocol Amendments , 2011 .

[2]  David Moher,et al.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials , 2013, BMJ.

[3]  J. D. Miller,et al.  Registering clinical trial results: the next step. , 2010, JAMA.

[4]  K. Abbasi,et al.  Trial protocols at the BMJ , 2004, BMJ : British Medical Journal.

[5]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of clinical epidemiology.

[6]  A. Hrõbjartsson,et al.  Constraints on publication rights in industry-initiated clinical trials. , 2006, JAMA.

[7]  S. Evans,et al.  Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet , 2008, The Lancet.

[8]  J. Siegel.  Editorial review of protocols for clinical trials. , 1990 .

[9]  Douglas G Altman,et al.  Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols , 2008, BMJ : British Medical Journal.

[10]  Thomas Kaiser,et al.  Impact of document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications , 2012, BMJ : British Medical Journal.

[11]  A. Hrõbjartsson,et al.  Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory. , 2009, Journal of clinical epidemiology.

[12]  I. Sim,et al.  Clinical trial registration: transparency is the watchword , 2006, The Lancet.

[13]  B. Djulbegovic,et al.  Published methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocols. , 2012, Journal of clinical epidemiology.

[14]  K. Lee,et al.  Korean translation of the CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials , 2014, Epidemiology and health.

[15]  David Moher,et al.  Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa , 2012, Systematic Reviews.

[16]  Harold L. Moses,et al.  A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program , 2010 .

[17]  P. Gøtzsche,et al.  Access to data in industry-sponsored trials , 2011, The Lancet.

[18]  Kent Johnson,et al.  The power of the protocol , 2002, The Lancet.

[19]  David Moher,et al.  Guidelines for randomized clinical trial protocol content: a systematic review , 2012, Systematic Reviews.

[20]  A. Hrõbjartsson,et al.  Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study , 2005, BMJ : British Medical Journal.

[21]  A. Chan.  Out of sight but not out of mind: how to search for unpublished clinical trial evidence , 2012, BMJ : British Medical Journal.

[22]  C. Deangelis,et al.  Strengthening the credibility of clinical research , 2010, The Lancet.

[23]  T. Lancet.  Strengthening the credibility of clinical research , 2010, The Lancet.

[24]  D. Moher,et al.  Protocols, probity, and publication , 2009, The Lancet.

[25]  Douglas G Altman,et al.  Comparison of protocols and registry entries to published reports for randomised controlled trials. , 2011, The Cochrane database of systematic reviews.

[26]  Ida Sim,et al.  Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1) , 2005, BMJ : British Medical Journal.

[27]  D. Moher,et al.  Guidance for Developers of Health Research Reporting Guidelines , 2010, PLoS medicine.

[28]  P. van der Veer,et al.  Spirit , 2011, American Afterlives.

[29]  J. Habbema,et al.  Subgroup Analysis and Covariate Adjustment in Randomized Clinical Trials of Traumatic Brain Injury: A Systematic Review , 2005, Neurosurgery.

[30]  A. Hrõbjartsson,et al.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.

[31]  D. Moher,et al.  Developing a guideline for clinical trial protocol content: Delphi consensus survey , 2012, Trials.

[32]  E. Turner,et al.  A Taxpayer-Funded Clinical Trials Registry and Results Database , 2004, PLoS medicine.

[33]  David Coultas,et al.  Ethical considerations in the interpretation and communication of clinical trial results. , 2007, Proceedings of the American Thoracic Society.

[34]  J. Grimshaw,et al.  Lead editorial: Trials – using the opportunities of electronic publishing to improve the reporting of randomised trials , 2006, Trials.

[35]  J. Siegel.  Editorial review of protocols for clinical trials. , 1990, The New England journal of medicine.

[36]  David Moher,et al.  The Good Clinical Practice guideline: a bronze standard for clinical research , 2005, The Lancet.

[37]  Karmela Krleža-Jerić,et al.  Reporting of Methodologic Information on Trial Registries for Quality Assessment: A Study of Trial Records Retrieved from the WHO Search Portal , 2010, PloS one.

[38]  J. Ioannidis,et al.  Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias , 2008, PloS one.

[39]  D G Altman,et al.  Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists , 2011, BMJ : British Medical Journal.

[40]  J. Abraham.  The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use , 2009 .

[41]  Douglas G Altman,et al.  Ghost Authorship in Industry-Initiated Randomised Trials , 2007, PLoS medicine.

[42]  A. Colevas,et al.  Adverse event reporting in publications compared with sponsor database for cancer clinical trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Dawn L. Hershman,et al.  Author Contributions Conception and design: All authors Collection and assembly of data: All authors Data analysis and interpretation: All authors Manuscript writing: All authors Final approval of manuscript: All authors , 2014 .

[44]  Sally Hopewell,et al.  The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed , 2010, BMJ : British Medical Journal.

[45]  Access to clinical trial data , 2011, BMJ : British Medical Journal.

[46]  David Moher,et al.  CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. , 2010, Obstetrics and gynecology.

[47]  Ana Marusic,et al.  Clinical Trial Registration Looking Back and Moving Ahead , 2007, Annals of Internal Medicine.

[48]  Drummond Rennie,et al.  Trial registration: a great idea switches from ignored to irresistible. , 2004, JAMA.